FREE Account Opening + No Clearing Fees
Loading...

ANG Lifesciences IPO vs Lexus Granito IPO

Comparision between ANG Lifesciences IPO and Lexus Granito IPO.

IPO Details

ANG Lifesciences IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Lexus Granito IPO is a SME Book Built Issue proposed to list at NSE SME.

  ANG Lifesciences IPO Lexus Granito IPO
Logo ANG Lifesciences IPO Logo Lexus Granito IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Book Built Issue
Listing At BSE SME NSE SME
Lead Managers Oneview Corporate Advisors Pvt. Ltd. Pantomath Capital Advisors Pvt Ltd
Registrar Bigshare Services Pvt Ltd Bigshare Services Pvt Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of ANG Lifesciences IPO is up to ₹12.01 Cr whereas the issue size of the Lexus Granito IPO is up to ₹25.92 Cr. The final issue price of ANG Lifesciences IPO is ₹80.00 per share and of Lexus Granito IPO is ₹45.00 per share.

  ANG Lifesciences IPO Lexus Granito IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹41.00 per share
Issue Price (Upper) ₹45.00 per share
Issue Price (Final) ₹80.00 per share ₹45.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 1600 shares 3000 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 15,00,800 shares 57,60,000 shares
Issue Size Total (Amount) up to ₹12.01 Cr up to ₹25.92 Cr

IPO Timetable

ANG Lifesciences IPO opens on Aug 29, 2017, while Lexus Granito IPO opens on Aug 09, 2017. The closing date of ANG Lifesciences IPO and Lexus Granito IPO is Aug 31, 2017, and Aug 11, 2017, respectively.

  ANG Lifesciences IPO Lexus Granito IPO
Anchor Bid Date
Issue Open Aug 29, 2017 Aug 09, 2017
Issue Close Aug 31, 2017 Aug 11, 2017
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

ANG Lifesciences IPO P/E ratio is , as compared to Lexus Granito IPO P/E ratio of .

  ANG Lifesciences IPO Lexus Granito IPO
Financial
Summary of financial Information (Consolidated)
Particulars For the year/period ended (Rs. in Lacs)
31-Mar-17 31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13
Total Assets 16,439.35 9,798.09 5,910.54 6,022.14 6,972.31
Total Revenue 16,473.11 10,226.87 8,090.04 5,925.34 6,365.39
Profit After Tax 508.82 320.20 203.04 31.99 156.17
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the ANG Lifesciences IPO retail investors (RII) are offered 7,12,000 shares while in Lexus Granito IPO retail investors are offered 7,12,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in ANG Lifesciences IPO and 16,38,000 shares in Lexus Granito IPO.

  ANG Lifesciences IPO Lexus Granito IPO
Anchor Investor Reserveration
Market Maker Reserveration 3,00,000 shares
QIB 0 shares 16,38,000 shares
NII 7,12,000 shares 19,11,000 shares
RII 7,12,000 shares 19,11,000 shares
Employee
Others
Total 14,24,000 shares 54,60,000 shares

Bids Received (Subscription)

ANG Lifesciences IPO subscribed in total, whereas Lexus Granito IPO subscribed 37.41x.

  ANG Lifesciences IPO Lexus Granito IPO
QIB (times) 3.22x
NII (times) 65.12x
Big NII (times)
Small NII (times)
RII (times) 39.01x
Employee (times)
Other (times)
Total (times) 37.41x

Comments

Add a public comment...